1: Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era. de Miguel S, Domenech M, González-Camacho F, Sempere J, Vicioso D, Sanz JC, García Comas L, Ardanuy C, Fenoll A, Yuste J. Clinical Infectious Diseases, ciaa1483. 2020. DOI: 10.1093/cid/ciaa1483
2: New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia. Tarancón R, Domínguez-Andrés J, Uranga S, Ferreira AV, Groh LA, Domenech M, González-Camacho F, Riksen NP, Aguilo N, Yuste J, Martín C, Netea MG. PLoS Pathog. 2020 Apr; 16(4):e1008404. DOI: 10.1371/journal.ppat.1008404
3: Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain. Sempere J, de Miguel S, González-Camacho F, Yuste J, Domenech M. Front Microbiol. 2020 Feb 27; 11:309. DOI: 10.3389/fmicb.2020.00309
4: Enfermedad neumocócica invasiva. Situación actual, predicción de serotipos emergentes y futuras vacunas. Mirian Domenech; Fernando González-Camacho; Julio Sempere; Jose Enrique Yuste. Libro: Vacunas 2019. pp. 113 - 128. Campins Martí M, Moraga Llop FA, editores, 2019. ISBN 978-84-09-15297-1.
5: Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract. Corsini B, Díez-Martínez R, Aguinagalde L, González-Camacho F, García-Fernández E, Letrado P, García P, Yuste J. Antimicrob Agents Chemother. 2018 May 25;62(6). DOI: 10.1128/AAC.02212-17
6: Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract. Domenech M, Sempere J, de Miguel S, Yuste J. Front Immunol. 2018 Nov 20; 9:2700. DOI: 10.3389/fimmu.2018.02700
7: Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus. Letrado P, Corsini B, Díez-Martínez R, Bustamante N, Yuste JE, García P. Future Microbiol. 2018 Sep;13:1215-1223. DOI:10.2217/fmb-2018-0077
8. Modulation of Haemophilus influenzae interaction with hydrophobic molecules by the VacJ/MlaA lipoprotein impacts strongly on its interplay with the airways. Fernández-Calvet A, Rodríguez-Arce I, Almagro G, Moleres J, Euba B, Caballero L, Martí S, Ramos-Vivas J, Bartholomew TL, Morales X, Ortíz-de-Solórzano C, Yuste JE, Bengoechea JA, Conde-Álvarez R, Garmendia. J. Sci Rep. 2018 May 2;8(1):6872. DOI: 10.1038/s41598-018-25232-y
9: PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease. Ramos-Sevillano E, Urzainqui A, de Andrés B, González-Tajuelo R, Domenech M, González-Camacho F, Sánchez-Madrid F, Brown JS, García E, Yuste J. PLoS Pathog. 2016 Mar 14;12(3):e1005500. DOI: 10.1371/journal.ppat.1005500
10: Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis. Corsini B, Aguinagalde L, Ruiz S, Domenech M, Antequera ML, Fenoll A, García P, García E, Yuste J. Vaccine. 2016 Dec 7;34(50):6148-6157. DOI: 10.1016/j.vaccine.2016.11.001
11: DiiA is a novel dimorphic cell wall protein of Streptococcus pneumoniae involved in invasive disease. Escolano-Martínez MS, Domenech A, Yuste J, Cercenado MI, Ardanuy C, Liñares J, de la Campa AG, Martin-Galiano AJ. J Infect. 2016 Jul;73(1):71-81. DOI: 10.1016/j.vaccine.2015.08.009
12: Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Ramos-Sevillano E, Urzainqui A, Campuzano S, Moscoso M, González-Camacho F, Domenech M, Rodríguez de Córdoba S, Sánchez-Madrid F, Brown JS, García E, Yuste J. Infect Immun. 2015 Feb;83(2):591-603. DOI: 10.1128/IAI.02811-14
13: Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune Response. Aguinagalde L, Corsini B, Domenech A, Domenech M, Cámara J, Ardanuy C, García E, Liñares J, Fenoll A, Yuste J. PLoS One. 2015 Sep 14;10(9):e0137565. DOI: 10.1371/journal.pone.0137565
14: Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination. Fenoll A, Granizo JJ, Giménez MJ, Yuste J, Aguilar L. Vaccine. 2015 Oct 13;33(42):5691-5699. DOI: 10.1016/j.vaccine.2015.08.009
15: Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Domenech M, Ramos-Sevillano E, García E, Moscoso M, Yuste J. Infect Immun. 2013 Jul;81(7):2606-15. DOI: 10.1128/IAI.00491-13